Axsome Therapeutics Announces FDA Approval of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| (NASDAQ: AXSM) | Delayed: 174.34 -2.74 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $177.08 | 52 Week High | $15.74 | |||
| Open | $176.52 | 52 Week Low | $5.37 | |||
| Day High | $176.52 | P/E | N/A | |||
| Day Low | $169.30 | EPS | $0.00 | |||
| Volume | 1,367,837 | |||||
